Effect on stroke of different progestagens in low oestrogen dose oral contraceptives

Lancet

Volumn 354, Issue 9175, 1999, Pages 301-302

  Poulter, N R ^a   Chang, C L ^a   Farley, T M M ^c   Marmot, M G ^b   Meirik, O ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c WORLD BANK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; ESTROGEN; GESTAGEN; GESTODENE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK; STROKE;

EID: 0033600423     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01013-2     Document Type: Article

References (5)

1. Effect of different progestagens in low oestrogen oral contraceptives on venus thromboembolic disease. Lancet. 346:1995;1582-1588.
2. Heinemann LAJ, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R, and the Transnational Research Group on Oral Contraceptives and the Health of Young Women. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women. BMJ 1997; 315: 1502-04.
3. Lidegaard O., Kreiner S. Cerebral thrombosis and oral contraceptives: a case-control study. Contraception. 357:1998;303-314.
4. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives: description and validation of methods. J Clin Epidemiol. 48:1995;1513-1547.
5. Ischaemic stroke and combined oral contraceptives: results of an international multicentre case-control study. Lancet. 348:1996;498-505.